Randomised, double-blind, placebo-controlled trial of ivabradine in patients with acute coronary syndrome: Effects of the i f current inhibitor ivabradine on reduction of inflammation markers in patients with acute coronary syndrome-RIVIERA trial study design and rationale

  1. Dominguez-Rodriguez, A.
  2. Fard, S.S.
  3. Abreu-Gonzalez, P.
  4. Bosa-Ojeda, F.
  5. Consuegra-Sanchez, L.
  6. Jiménez-Sosa, A.
  7. Grande, A.S.
  8. Kaski, J.C.
Cardiovascular Drugs and Therapy

ISSN: 0920-3206

Year of publication: 2009

Volume: 23

Issue: 3

Pages: 243-247

Type: Article

DOI: 10.1007/S10557-009-6164-9 GOOGLE SCHOLAR